Loading clinical trials...
Loading clinical trials...
The purpose of this trial is to evaluate the safety and tolerability of multiple (3) intradermal doses of RXI-109 at small surgical incisions in the abdominal skin of healthy volunteers. The effect of...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
RXi Pharmaceuticals, Corp.
NCT07153393 · Skin Aging of Face and Hands, Cicatrix, and more
NCT04824612 · Keloid, Cicatrix
NCT04066946 · Cicatrix
NCT01789346 · Scar, Surgical Scar, and more
NCT04034615 · Cicatrix
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions